Results 251 to 260 of about 549,827 (310)

Biosample Donation Intentions of Patients with Infectious Disease Based on the Theory of Planned Behavior: A Qualitative Study. [PDF]

Infect Drug Resist
Wang W, Pan M, Liu Y, Wang J, Zhou J, Zhao Y, Xie P, Dong H, Yi C, Sun H.   +9 more
europepmc   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

British Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang, Chen‐Han Chueh, Chien‐Yu Tseng, Christopher N. Kaufmann, Earl J. Morris, Chiao‐En Wu, Yi‐Wen Tsai   +6 more
wiley   +1 more source

Health of international students in Canada (2013-2024): a scoping review of peer-reviewed and grey literature. [PDF]

BMJ Public Health
Balkaran D, Lucchese A, Terebessy E, Cunningham J, Bhangu M, Siddiqi A, Banerjee AT, Thakore P, Kaur P, Guttmann A, Wanigaratne S.   +10 more
europepmc   +1 more source

Community-level Health and Socioeconomic Disparities in Coccidioidomycosis: Insights from the Social Deprivation and Healthy Places Indices. [PDF]

Med Mycol
Nair N, Kaur E, Diaz P, Chan Golston A, Sivasubramanian G.   +4 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Real-World Impact of Insurance Changes on Long-acting Cabotegravir Plus Rilpivirine Delivery. [PDF]

Open Forum Infect Dis
Davis JM, O'Neill J, Lyden E, Bares SH.
europepmc   +1 more source

Evaluation of economic and social measures [PDF]

, 2002
Zachar, Dusan
core  

Estimation of the current healthcare costs of gout in Liaoning Province from 2015 to 2022 based on the SHA2011 accounting system. [PDF]

Front Public Health
Shi X, Zheng F, Wan Q, Chai P, Wang G, Pang Z, Ma Y.   +6 more
europepmc   +1 more source

Higher education : Northern Ireland domiciled higher education applicants : an analysis of UCAS data, 2003/04 academic year [PDF]

, 2005

core  

Examining health system stakeholder-reported barriers and solutions to foregut cancer care. [PDF]

Am J Surg
Sanghera J, Liapis I, Nair N, Holland M, Tripathi M, Hearld L, Mehari K, Bhatia S, Fonseca AL.   +8 more
europepmc   +1 more source